Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 219931-45-0
2. Chembl1163069
3. [(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl N-[(2s,3s)-2-amino-3-methylpentanoyl]sulfamate
4. Aminoacyltrnasynthetase-in-1
5. Bdbm50222902
6. 5'-o-[(l-isoleucylamino)sulfonyl]adenosine
7. Hy-108939
8. Cs-0032269
| Molecular Weight | 459.5 g/mol |
|---|---|
| Molecular Formula | C16H25N7O7S |
| XLogP3 | -2 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 8 |
| Exact Mass | 459.15361734 g/mol |
| Monoisotopic Mass | 459.15361734 g/mol |
| Topological Polar Surface Area | 226 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 738 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Aminoacyl tRNA synthetase-IN-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aminoacyl tRNA synthetase-IN-1, including repackagers and relabelers. The FDA regulates Aminoacyl tRNA synthetase-IN-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aminoacyl tRNA synthetase-IN-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Aminoacyl tRNA synthetase-IN-1 supplier is an individual or a company that provides Aminoacyl tRNA synthetase-IN-1 active pharmaceutical ingredient (API) or Aminoacyl tRNA synthetase-IN-1 finished formulations upon request. The Aminoacyl tRNA synthetase-IN-1 suppliers may include Aminoacyl tRNA synthetase-IN-1 API manufacturers, exporters, distributors and traders.
click here to find a list of Aminoacyl tRNA synthetase-IN-1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Aminoacyl tRNA synthetase-IN-1 DMF (Drug Master File) is a document detailing the whole manufacturing process of Aminoacyl tRNA synthetase-IN-1 active pharmaceutical ingredient (API) in detail. Different forms of Aminoacyl tRNA synthetase-IN-1 DMFs exist exist since differing nations have different regulations, such as Aminoacyl tRNA synthetase-IN-1 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Aminoacyl tRNA synthetase-IN-1 DMF submitted to regulatory agencies in the US is known as a USDMF. Aminoacyl tRNA synthetase-IN-1 USDMF includes data on Aminoacyl tRNA synthetase-IN-1's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Aminoacyl tRNA synthetase-IN-1 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Aminoacyl tRNA synthetase-IN-1 suppliers with USDMF on PharmaCompass.
Aminoacyl tRNA synthetase-IN-1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aminoacyl tRNA synthetase-IN-1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aminoacyl tRNA synthetase-IN-1 GMP manufacturer or Aminoacyl tRNA synthetase-IN-1 GMP API supplier for your needs.
A Aminoacyl tRNA synthetase-IN-1 CoA (Certificate of Analysis) is a formal document that attests to Aminoacyl tRNA synthetase-IN-1's compliance with Aminoacyl tRNA synthetase-IN-1 specifications and serves as a tool for batch-level quality control.
Aminoacyl tRNA synthetase-IN-1 CoA mostly includes findings from lab analyses of a specific batch. For each Aminoacyl tRNA synthetase-IN-1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aminoacyl tRNA synthetase-IN-1 may be tested according to a variety of international standards, such as European Pharmacopoeia (Aminoacyl tRNA synthetase-IN-1 EP), Aminoacyl tRNA synthetase-IN-1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aminoacyl tRNA synthetase-IN-1 USP).
LOOKING FOR A SUPPLIER?
